Bioactive Products
| Cat. No. | Information |
| CFN90471 | Brassicasterol Brassicasterol may be a relevant additional biomarker in Alzheimer's disease (AD). |
| CFN97945 | (-)-Variabilin Variabilin, a novel inhibitor of human platelet aggregation, it is a potent RGD (Arg-Gly-Asp)-containing antagonist of the fibrinogen receptor glycoprotein IIb-IIIa (GPIIb-IIIa; αIIbβ3) and the vitronectin receptor αvβ3.Variabilin is also an antimicrobial furanosesterterpene. Variabilin is an inhibitor of human secretory and cytosolic phospholipase A2 (PLA2) activities that controls eicosanoid production in vitro and in vivo, inhibits neutrophil degranulation and superoxide generation in vitro and shows anti-inflammatory activity after topical or p.o. administration to mice. |
| CFN90611 | 4-Beta-Hydroxycholesterol 4-Beta-hydroxycholesterol is a new endogenous CYP3A marker. 4-Beta-Hydroxycholesterol has exceptionally slow elimination and high plasma concentration properties, may it is a potential role of 4-Beta-Hydroxycholesterol as a ligand for the nuclear. |
| CFN90618 | Swertianolin Swertianolin shows anti-acetylcholinesterase activity effects, it shows significant hepatoprotective effect in the liver damage model induced by alpha-naphthylisot hiocyanate. Swertianolin can scavenge superoxide and hydroxyl radicals with the studying method of the autoxidation of Pyrogallol and afenton. |
| CFN93101 | trans-4-phenylbut-3-en-2-one trans-4-Phenylbut-3-en-2-one and 1,2-dichloro-4-nitrobenzene are marker substrates for the mouse Yb2 and Yb1 subunits respectively. |
